Article Type
Changed
Tue, 12/13/2016 - 12:08
Display Headline
HMG-CoA reductase inhibitors

References

Article PDF
Author and Disclosure Information

Donald G. Vidt, MD

Allan W. Bakst, PhramD, Rph

Michael D. Cressman, DO

Byron J. Hoogwerf, MD

Douglas S. Moodie, MD

Jeffrey W. Olin, DO

Cheryl E. Weinstein, MD

Issue
Cleveland Clinic Journal of Medicine - 55(1)
Publications
Topics
Page Number
93-100
Legacy Keywords
Antilipemic agents, Hyperlipoproteinemia, drug therapy
Author and Disclosure Information

Donald G. Vidt, MD

Allan W. Bakst, PhramD, Rph

Michael D. Cressman, DO

Byron J. Hoogwerf, MD

Douglas S. Moodie, MD

Jeffrey W. Olin, DO

Cheryl E. Weinstein, MD

Author and Disclosure Information

Donald G. Vidt, MD

Allan W. Bakst, PhramD, Rph

Michael D. Cressman, DO

Byron J. Hoogwerf, MD

Douglas S. Moodie, MD

Jeffrey W. Olin, DO

Cheryl E. Weinstein, MD

Article PDF
Article PDF

References

References

Issue
Cleveland Clinic Journal of Medicine - 55(1)
Issue
Cleveland Clinic Journal of Medicine - 55(1)
Page Number
93-100
Page Number
93-100
Publications
Publications
Topics
Article Type
Display Headline
HMG-CoA reductase inhibitors
Display Headline
HMG-CoA reductase inhibitors
Legacy Keywords
Antilipemic agents, Hyperlipoproteinemia, drug therapy
Legacy Keywords
Antilipemic agents, Hyperlipoproteinemia, drug therapy
Article Source

PURLs Copyright

Inside the Article

Article PDF Media